OCULAR THERAPEUTIX, INC (OCUL) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2015: -$33.74M2016: -$34.00M2017: -$50.47M2018: -$49.23M2019: -$77.58M2020: -$53.55M2021: -$65.55M2022: -$59.60M2023: -$70.23M2024: -$134.68M2025: -$204.88M-$204.88M
2015Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$204.88M-52.1%
2024-$134.68M-91.8%
2023-$70.23M-17.8%
2022-$59.60M+9.1%
2021-$65.55M-22.4%
2020-$53.55M+31.0%
2019-$77.58M-57.6%
2018-$49.23M+2.5%
2017-$50.47M-48.4%
2016-$34.00M-0.8%
2015-$33.74M